Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Argus Adjusts Medtronic's Price Target to $150 From $135, Reiterates Buy Rating

06/03/2021 | 08:25am EDT


© MT Newswires 2021
All news about MEDTRONIC PLC
09/14Medtronic to Seek Acquisitions
CI
09/14MEDTRONIC : Says US Patent Office Rejects Axonics' Challenge to Bladder Device P..
MT
09/13MEDTRONIC : U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtr..
PR
09/13MEDTRONIC : Collaboration with Mpirik to Address Disparities in Care Associated ..
PR
09/13Medtronic Collaboration with Mpirik to Address Disparities in Care Associated..
CI
09/10MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
09/09MEDTRONIC : 2021 Virtual Wells Fargo Healthcare Conference Presentation
PU
09/07MEDTRONIC : Executives to Speak at Upcoming Investor Conferences
AQ
09/07MEDTRONIC : Announces NAVABLATE Study Results Released in Late-Breaking Podium P..
PR
09/07Medtronic plc Announces NAVABLATE Study Results Released in Late-Breaking Pod..
CI
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 995 M - -
Net income 2022 5 704 M - -
Net Debt 2022 20 694 M - -
P/E ratio 2022 32,7x
Yield 2022 1,85%
Capitalization 175 B 175 B -
EV / Sales 2022 5,92x
EV / Sales 2023 5,55x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Last Close Price 129,70 $
Average target price 145,92 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC10.72%176 193
ABBOTT LABORATORIES16.39%225 928
BECTON, DICKINSON AND COMPANY4.98%75 436
HOYA CORPORATION30.10%63 907
ALIGN TECHNOLOGY, INC.36.29%57 543
SARTORIUS STEDIM BIOTECH81.73%57 390